Navigation Links
Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
Date:4/22/2009

EXTON, Pa., April 22 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its third quarter and first nine months of fiscal year 2009.

Third Quarter Fiscal 2009 Snapshot

  • EPS of $0.42, meeting the high end of previous guidance of $0.40-$0.42.
  • EBITDA of $9.2 million.
  • Operating margin of 37%.
  • Operating cash flow of $8.4 million.
  • Biomaterial sales of $12.9 million, representing an increase of 3% from third quarter of prior fiscal year.
  • Endovascular sales of $947,000, representing a decrease of 39% from third quarter of prior fiscal year.
  • Angio-Seal(TM) royalties of $5.3 million, essentially flat from third quarter of prior fiscal year. The negative impact of foreign currency translation decreased third quarter royalties by approximately $300,000.
  • Record orthopaedic royalties of $1.5 million, representing an increase of 27% from third quarter of prior fiscal year.
  • IDE submission for Cartilage US clinical trial in February 2009.
  • OsseoFit(TM) CE Mark Approval obtained in March 2009.

President and CEO Commentary

"Our third quarter performance was strong both from an operating perspective, as well as our product development pipeline," said Joe Kaufmann, President and CEO of the Company. "Third quarter revenue and earnings have kept pace with our targets despite the ongoing difficult economic environment. Our balance sheet continues to be strengthened by generating $8.4 million in operating cash flow this quarter, and $22
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
2. Kensey Nash Announces 600,000 Share Stock Repurchase Program
3. Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
4. Kensey Nash Announces Appointment of Chief Financial Officer
5. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
6. Kensey Nash Announces Director Resignation
7. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
8. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
9. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference
10. Kensey Nash Provides 4th Quarter Fiscal 2008 and Fiscal Year 2009 Guidance
11. Kensey Nash Announces the Closing on its Sale of the Endovascular Business to Spectranetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... Aliso Viejo, CA (PRWEB) May 24, 2015 ... for use in Final Cut Pro X. Utilize ProPin to ... locations in a given scene. , ProPin allows users ... are completely customizable in FCPX. With on-screen controls, video editors ... Studios allows users to pin and mark with absolute ease. , ...
(Date:5/24/2015)... May 24, 2015 ... CEO - The students were ... at the fourth annual A Day ... at Geneva National in Lake Geneva. ...     -Badger High School,         Jonathan Alfonso,         Bridget ...
(Date:5/23/2015)... 2015 On May 13, Nithyananda Yoga ... youngster's yogic power learned through meditation and initiation at ... Bangalore, India. , Yogamaatha, a nine-year-old girl from North ... profile professionals attending the 2015 Business Advocacy Summit at ... blindfolded. , In a demonstration that lasted three ...
(Date:5/23/2015)... 23, 2015 On Wednesday, May 20, ... company has been the target of a sophisticated cyberattack,” ... the company’s ongoing Information Technology (IT) security efforts in ... , The most notable attack on health insurers was ... the nation’s second largest health insurer, revealed that they ...
(Date:5/23/2015)... A live auction will be held to sell over 5,200 ... medical facilities around the United States. Various types of ... exam and much more. , The live auction will ... at 9:00am CDT each day. The equipment is at their ... IL 60160. Anyone can participate in the auction including ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... The 2009-2010 INFORMS Society for Marketing Science/Marketing Science ... professors at the University of Passau and the ... Healthcare AG in their marketing investment planning for ... product portfolio in five European markets. The prize-winning ...
... ... Business , ... NY (PRWEB) June 18, 2010 -- LaVoie Group, a leader in life sciences and pharmaceutical ... Mr. Pilato will be based in New York, NY and will lead one of agency,s ...
... five lifestyle factors, international study finds , FRIDAY, June 18 ... 10 risk factors account for 90 percent of all the ... potent role. , Of that list, five risk factors usually ... diet and physical activity -- are responsible for a full ...
... Italy, Friday 18 June 2010: Systemic Lupus Erythematosus ... patients from France report that their rheumatic conditions ... according to research presented today at EULAR 2010, ... Rheumatism in Rome, Italy. Furthermore, findings of the ...
... Systemic Lupus Erythematosus (SLE) Treatment and Research Group (CSTAR) announced ... EULAR 2010, the Annual Congress of the European League Against ... has been scarce to date; but now CSTAR provides the ... date the registry has collated data from 2,104 SLE patients ...
... expression of a transporter protein called the Breast Cancer ... indicate higher disease activity and could be a barrier ... to the results of a study presented today at ... Against Rheumatism in Rome, Italy. In ...
Cached Medicine News:Health News:Prize-winning budgeting model aims for more effective marketing spending 2Health News:LaVoie Group Adds Carey Pilato As Vice President Based In New York 2Health News:Ninety Percent of Stroke Risk Due to 10 Risk Factors 2Health News:Ninety Percent of Stroke Risk Due to 10 Risk Factors 3Health News:Sex lives of patients are negatively affected by RA and SLE 2Health News:Sex lives of patients are negatively affected by RA and SLE 3Health News:Chinese systemic lupus erythematosus data reveal differences in epidemiology across continents 2Health News:Expression of certain transporter proteins may predict resistance to drug therapy 2
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx ... today announced a peer-reviewed publication of the results ... evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for the ... controlled adverse environment (CAE ® ) model.  The ... the results, which were previously disseminated by the ...
(Date:5/22/2015)... 22, 2015 According to a ... Product (Consumables, Instruments, Services), by Test Type (Indirect, Enzyme-based, ... Cytometry), by End Users - Global Forecast to 2020", ... expected to reach $736.85 Million by 2020 from $452.36 ... Browse 71 market data Tables and ...
(Date:5/22/2015)... InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), ... that its CGuard TM Embolic Prevention System reported positive ... Musialek , at the EuroPCR conference on May ... PARADIGM, an investigator-initiated P rospective evaluation of ... revascularization I n symptomatic and increased-risk asymptomatic carotid artery ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: